STAT Expert Advantage
Exploring gene therapy treatments in the hemophilia space including those from BioMarin, Spark Therapeutics, and UniQure
Related Articles
Tomorrow’s Trailblazers in Science
On April 25th, join STAT for a conversation with past all-star Wunderkinds to see where they are now and hear their most inspiring and innovative…
EMTALA, a vital health law you’ve never heard of, is in danger
EMTALA is a unique law protecting a right to emergency care in the U.S. States shouldn’t be able to chip away at the protections it…
In a scientific first, researchers use CRISPR base editing to treat liver disease in fetal monkeys
In a scientific first, researchers have used CRISPR base editing to treat liver disease in fetal monkeys.
Bashing accelerated approval isn’t supported by the data
The accelerated approval pathway works, though it isn’t a flawless oracle of therapeutic success. Perfect mustn’t be allowed to be the enemy of people with…
Telehealth startups see an opportunity in long-ignored, complex chronic diseases
Easily a decade can pass before someone with a complex chronic condition gets a proper diagnosis. New telehealth companies aim to shorten that time and…
Pharmalittle: We’re reading about Lilly buying a plant, a Pfizer antibiotic, and more
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
Looking for signs of growth in Biogen’s earnings
Biogen CEO Chris Viehbacher has been praised for reducing operating expenses. A return to revenue growth is still on the to-do list, however.
Trump surrogates hint at how he could reshape U.S. health care policy
Donald Trump’s health care priorities remain fuzzy. But one thing is certain: A second Trump administration would put its own stamp on a host of…
Accreditation agencies take on telehealth with new virtual care standards
The Joint Commission and the National Committee for Quality Assurance will launch updated accreditation programs for telehealth providers.
Telehealth startups see an opportunity in long-ignored, complex chronic diseases
Easily a decade can pass before someone with a complex chronic condition gets a proper diagnosis. New telehealth companies aim to shorten that time and…